Posts

Technology PR

FischTank is pleased to announce that President Matthew Bretzius and Senior Account Director Kate Caruso-Sharpe will present an overview on corporate communications and media relations strategy with an emphasis on technology PR, for international technology companies at the CANUTE Program hosted by the Royal Consulate General of Denmark in New York on Wednesday, October 9.

Supported by the Ministry of Foreign Affairs in Denmark and Danske Bank, the Royal Consulate General of Denmark in New York is hosting more than a dozen select technology startups from Denmark for an entrepreneurial bootcamp, offering a tailored program on how to successfully enter the U.S. market. During the three-day event, startup founders will engage with investors, recruitment specialists, and marketing experts to gain a better understanding of how to scale their company to one of the largest markets in the world.

Bretzius and Caruso-Sharpe will lead an interactive discussion centering on marketing and communications strategies that are critical to the successful launch into U.S. markets, including media relations, content marketing, search engine optimization, social media, and email marketing. Participating startups will have the opportunity to ask business-specific questions relating to their own marketing initiatives, while also learning about the work FischTank has done with a number of international brands, both startup and established, to develop and deploy effective messaging to reach U.S. business audiences. Technology PR remains a core practice area for FischTank for companies both domestic and abroad.

“Entering the U.S. market can be an overwhelming task for any international technology company, often leading to marketing and communications functions falling by the wayside,” said Matt Bretzius, President, FischTank Marketing and PR. “We look forward to discussing tactics to fully integrate and scale digital and traditional public relations activities so that companies flourish in their new markets and achieve the brand awareness necessary to stand apart.”

Following the educational portion of the program, VCs, business angels, accelerators, incubators, and others are invited to participate in this year’s Investor Day. During that event, ten selected startups from Denmark will pitch their tech businesses to a panel and audience with the goal of raising their next funding round to expand into the U.S. market. FischTank looks forward to providing technology PR insights for these companies.

“We are excited to bring some of the best startups Denmark has to offer to the U.S. for this valuable program. While many have found success in the Danish market, the next logical step is to expand to larger international audiences, and this event will give them a head start toward doing so,” said Mia Grosen, Founder of the CANUTE Program. “We look forward to working with FischTank and the other participating experts to provide the knowledge and resources our startups need to succeed on a global scale.”

Eric Fischgrund is an entrepreneur, writer, sports fan, music-lover, and founder and CEO of FischTank Marketing and PR, a marketing and communications firm based in NYC.

CHICAGO, Nov. 30, 2017 (GLOBE NEWSWIRE) — BIOLIFE4D, a biotech pioneer leveraging advances in tissue engineering to 3D print human organs viable for transplant, today announced it has retained FischTank Marketing and PR, a New York City-based firm, as its Agency of Record to conduct national and trade media outreach, generate awareness for its upcoming Regulation A+ equity crowdfunding campaign, and advise on all marketing and communications functions.

The relationship was established to support the Company as it seeks to raise its profile ahead of its equity fund raise in early 2018, and as it develops messaging and marketing strategy to generate awareness within the medical community. FischTank will seek to increase BIOLIFE4D’s overall exposure, develop and maintain external communications, and hone marketing strategies.

“As we continue to develop our technology and prepare for our Regulation A+ raise in early 2018, we felt it was crucial to establish a strong and consistent marketing and communications strategy, for both potential investors and key partners within the medical community,” said Steven Morris, CEO, BIOLIFE4D. “FischTank has the depth of experience we are looking for, having led biotech startups through this process before, with showcased results. We look forward to their guidance during this important time for our Company.”

BIOLIFE4D is a biotech startup focused on making human organ replacement commonplace globally using an approach that combines recent breakthroughs in regenerative medicine, stem cell biology, 3D printing techniques, and computing technology.

“What BIOLIFE4D is doing from an innovation standpoint is remarkable and something we are excited to be a part of – literally giving people the gift of time,” said Matthew Bretzius, President, FischTank Marketing and PR. “We look forward to working with the team to develop a sound messaging strategy and to generate awareness for the technology and the RegA+ fund raise, but also for general heart health.”

BBIOLIFE4D has filed a $50 million initial public offering with the Securities and Exchange Commission (SEC) under Regulation A+ equity crowdfunding rules, allowing everyday investors to help the company bring its groundbreaking cardiac tissue regeneration and organ replacement process to market.  The “Reg A+” rules, outlined under the 2012 Jumpstart Our Business Startups (JOBS) Act, allow companies to raise up to $50 million in equity from non-accredited investors and others.

To learn more about BIOLIFE4D and to express interest in investing visit https://biolife4d.com/invest/.

About BIOLIFE4D

BIOLIFE4D is a pioneering biotech company laser focused on leveraging advances in life sciences and tissue engineering to 3D bioprint a viable human heart suitable for transplant – lifesaving technology that gives patients the gift of time. With BIOLIFE4D, a patient-specific, fully functioning heart will be created through 3D bioprinting using the patient’s own cells – eliminating the well-known challenges of organ rejection and long donor waiting lists that plague existing organ transplant methods. Financed through equity crowdfunding, BIOLIFE4D is driving a movement to transform the treatment of heart disease, the leading cause of death among both men and women globally. Learn more and invest at biolife4d.com. Connect with us on social media on Twitter (@BIOLIFE4D), FacebookLinkedIn, and Instagram.

Although you are currently able to express your interest in investing, BIOLIFE4D Corporation is not yet accepting investments.  No money or other consideration is being solicited by the company at this time, and if sent in response, will not be accepted. No offer to buy the securities can be accepted and no part of the purchase price can be received until the offering statement is qualified, and any such offer may be withdrawn or revoked, without obligation or commitment of any kind, at any time before notice of its acceptance given after the qualification date. If you indicate interest, your indication of interest involves no obligation or commitment of any kind.

Eric Fischgrund is an entrepreneur, writer, sports fan, music-lover, and founder and CEO of FischTank Marketing and PR, a marketing and communications firm based in NYC.